News

The biggest surprise of 15-year-old Karina Moreira's life came knocking on her door Thursday, with a visit from none other than Gisele Bundchen herself, Fox 25 reports. Bundchen stopped by Moreira's home in Malden to lend some support to the ninth grader, who has been battling bone cancer since she was 12.

A new study suggests that women who eat more peanuts and tree nuts during pregnancy might be less likely to bear nut-allergic children, the Wall Street Journal reports. Researchers led by A. Lindsay Frazier, MD, of Dana-Farber/Boston Children's analyzed data from 8,205 children born to mothers who had reported their diets at or around the time of pregnancy.

For the Perry family, Christmas this year will be a little different, Today.com reports. The festivities will not be held at Grandma’s house, or at home in Nashua, NH, but in a hospital room at Dana-Farber/Boston Children’s where Owen, 12, is receiving treatment for acute myeloid leukemia.

An international consortium of scientists, including researchers at Dana-Farber/Boston Children's, is finding promising early results in a new gene therapy clinical trial they say may lead to an eventual long-term cure for SCID-X1, ABC News reports.

The Nebraska spring football game on April 6 was an unlikely setting for the year's most memorable sports moment, but then again, Jack Hoffman, a patient at Dana-Farber/Boston Children’s, is a most unusual little boy, Sports Illustrated reports.

(News release) Children with acute lymphoblastic leukemia (ALL), the most common form of pediatric cancer, can safely receive intravenous infusions of a reformulated mainstay of chemotherapy that has been delivered via painful intramuscular injection for more than 40 years, research suggests.

An international study led by Dana-Farber Cancer Institute and Boston Children's Hospital has shown that a new type of gene therapy may help boys with a fatal immune disorder commonly known as “bubble boy” disease, the Boston Business Journal reports.

Researchers report promising results of a gene therapy trial aimed at curing the genetic defect that causes some children to be born without immune defenses, a rare condition also known as “bubble boy” disease, NPR reports.